ATE22895T1 - Verbesserung der oralen absorption von carboxylsaeure-arzneimitteln durch bildung der (5- alkyl-2-oxo-1,3-dioxolen-4-yl)-methylester.
- Google Patents
Verbesserung der oralen absorption von carboxylsaeure-arzneimitteln durch bildung der (5- alkyl-2-oxo-1,3-dioxolen-4-yl)-methylester.
Info
Publication number
ATE22895T1
ATE22895T1AT82106172TAT82106172TATE22895T1AT E22895 T1ATE22895 T1AT E22895T1AT 82106172 TAT82106172 TAT 82106172TAT 82106172 TAT82106172 TAT 82106172TAT E22895 T1ATE22895 T1AT E22895T1
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co IncfiledCriticalMerck & Co Inc
Priority claimed from EP82106172Aexternal-prioritypatent/EP0070013B1/de
Application grantedgrantedCritical
Publication of ATE22895T1publicationCriticalpatent/ATE22895T1/de
AT82106172T1981-07-131982-07-12Verbesserung der oralen absorption von carboxylsaeure-arzneimitteln durch bildung der (5- alkyl-2-oxo-1,3-dioxolen-4-yl)-methylester.
ATE22895T1
(de)